Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

by Franco Locatelli, Gerhard Zugmaier, Noemi Mergen, Peter Bader, Sima Jeha, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, Rupert Handgretinger, Benoit Brethon, Claudia Rossig, Christiane Chen-Santel
Published 2021-02-01

Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearra...

by Benoît Brethon, Elodie Lainey, Elodie Lainey, Aurélie Caye-Eude, Aurélie Caye-Eude, Audrey Grain, Odile Fenneteau, Karima Yakouben, Julie Roupret-Serzec, Julie Roupret-Serzec, Lou Le Mouel, Hélène Cavé, Hélène Cavé, André Baruchel, André Baruchel
Published 2021-02-01

Impact of the First Wave of COVID-19 on Pediatric Oncology and Hematology: A Report from the French Society of Pediatric Oncology

by Jérémie Rouger-Gaudichon, Eric Thébault, Arthur Félix, Aurélie Phulpin, Catherine Paillard, Aurélia Alimi, Benoît Brethon, Elodie Gouache, Sandra Raimbault, Eva de Berranger, Marilyne Poirée, Séverine Bouttefroy, Nicolas André, Virginie Gandemer, on behalf of Société Française de lutte contre les Cancers et leucémies de l’Enfant et de l’adolescent (SFCE)
Published 2020-11-01